and follow-up are necessary to avoid unnecessary or excessively prolonged use of HF.
Disclosure Statement
Y.V. is consultant for ASPEN, Biocodex and United Pharmaceuticals. S.S. has participated as a consultant and/or speaker for Arla Foods, Danone/Nutricia, IMS Health, Menarini, Milte and Nestlé.
References
1 Koletzko S, Niggemann B, Arato A, et al: Diagnostic approach and management of cow’s milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 2012;55:221-229.
2 Muraro A, Halken S, Arshad SH, et al: EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014;69:590-601.
3 Fiocchi A, Schünemann HJ, Brozek J, et al: Diagnosis and rationale for action against cow’s milk allergy (DRACMA): a summary report. J Allergy Clin Immunol 2010;126:1119-1128.
4 Du Toit G, Roberts G, Sayre PH, et al: Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015;372:803-813.
5 Nwaru BI, Hickstein L, Panesar SS, et al: Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy 2014;69:992-1007.
6 Perez-Machado MA, Ashwood P, Thomson MA, et al: Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003;33:2307-2315.
7 Tsabouri S, Douros K, Priftis KN: Cow’s milk allergenicity. Endocr Metab Immune Disord Drug Targets 2014;14:16-26.
8 Spuergin P, Walter M, Schiltz E, et al: Allergenicity of alpha-caseins from cow, sheep, and goat. Allergy 1997;52:293-298.
9 Mills EN, Mackie AR: The impact of processing on allergenicity of food. Curr Opin Allergy Clin Immunol 2008;8:249-253.
10 Thomas K, Herouet-Guicheney C, Ladics G, et al: Evaluating the effect of food processing on the potential human allergenicity of novel proteins: international workshop report. Food Chem Toxicol 2007;45:1116-1222.
11 El Mecherfi KE, Saidi D, Kheroua O, et al: Combined microwave and enzymatic treatments for β-lactoglobulin and bovine whey proteins and their effect on the IgE immunoreactivity. Eur Food Res Technol 2011;233:859-867.
12 Peñas E, Préstamo G, Baeza ML, et al: Effects of combined high pressure and enzymatic treatments on the hydrolysis and immunoreactivity of dairy whey proteins. Int Dairy J 2006;16:831-839.
13 Pescuma M, Hébert EM, Rabesona H, et al: Proteolytic action of Lactobacillus delbrueckii subsp. bulgaricus CRL 656 reduces antigenic response to bovine β-lactoglobulin. Food Chem 2011;127:487-492.
14 Ahmadova A, El-Ghaish S, Choiset Y, et al: Modification of IgE binding to β- and αS1-caseins by proteolytic activity of Lactobacillus helveticus A75. J Food Biochem 2012;37:491-500.
15 El-Ghaish S, Rabesona H, Choiset Y, et al: Proteolysis by Lactobacillus fermentum IFO3956 isolated from Egyptian milk products decreases immunoreactivity of αS1-casein. J Dairy Res 2011;9:1-8.
16 Vandenplas Y, Bathia J, Shamir R, et al: Hydrolyzed formulas for allergy prevention. J Pediatr Gastroenterol Nutr 2014;58:549-552.
17 Greer FR, Sicherer SH, Burks AW, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Allergy and Immunology: Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008;121:183-191.
18 Aas K: What makes an allergen an allergen? Allergy 1978;33:3-14.
19 van Beresteijn ECH, Peeters RA, Kaper J, et al: Molecular mass distribution, immunological properties and nutritive value of whey protein hydrolysates. J Food Protection 1994;57:619-625.
20 Puerta A, Diez-Masa JC, de Frutos M: Immunochromatographic determination of β-lactoglobulin and its antigenic peptides in hypoallergenic formulas. Int Dairy J 2006;16:406-414.
21 Selo I, Clemen TG, Bernard H, et al: Allergy to bovine β-lactoglobulin: specificity of human IgE to tryptic peptides. Clin Exp Allergy 1999;29:1055-1063.
22 Calvo MM, Gómez R: Peptidic profile, molecular mass distribution and immunological properties of commercial hypoallergenic infant formulas. Milchwissenschaft 2002;57:187-190.
23 Kneepkens CMF, Meijer Y: Clinical practice. Diagnosis and treatment of cow’s milk allergy. Eur J Pediatr 2009;168:891-896.
24 Vandenplas Y, Cruchet S, Faure C, et al: When should we use partially hydrolysed formulae for frequent gastro-intestinal symptoms and allergy prevention? Acta Paediatr 2014;103:689-695.
25 Zeiger RS: Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics 2003;111:1662-1671.
26 Osborn DA, Sinn J: Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2006;4:CD003664.
27 Fuertes E, Standl M, von Berg A, Lehmann I: Parental allergic disease before and after child birth poses similar risk for childhood allergies. Allergy 2015;70:873-876.
28 Alexander DD, Cabana MD: Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr 2010;50:422-430.
29 Szajewska H, Horvath A: Meta-analysis of the
